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Edited by Frances ShannonAbstract Polycyclic aromatic hydrocarbons (PAHs) such as
benzo(a)pyrene (BP) are toxic environmental contaminants
known to enhance production of pro-inﬂammatory cytokines
such as IL-1b. The present study was designed in order to deter-
mine whether TNFa, another cytokine acting in inﬂammation,
may also constitute a target for these chemicals. Both TNFa
mRNA and TNFa secretion levels were found to be enhanced
in human BP-treated macrophages. Dioxin, a contaminant acti-
vating the aryl hydrocarbon receptor (AhR) like PAHs, was also
shown to increase TNFa expression. BP-mediated TNFa induc-
tion was however not suppressed by AhR antagonists, making
unlikely the involvement of the typical AhR signalling pathway.
BP-exposure of macrophages did not enhance NF-jB DNA
binding activity, but it activated the MAP kinase ERK1/2. In
addition, the use of chemical inhibitors of extracellular signal-
regulated protein kinase (ERK) activation fully abrogated induc-
tion of TNFa production in BP-treated macrophages. These data
likely indicate that PAHs enhance TNFa expression in human
macrophages through an ERK-related mechanism. Such a regu-
lation may contribute to confer pro-inﬂammatory properties to
these widely-distributed environmental contaminants.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Polycyclic aromatic hydrocarbons (PAH) such as benzo(a)-
pyrene (BP) constitute major environmental contaminants.
They are usually generated through the combustion of fossil
fuels or wood, and are notably found in automobile exhaust,
cigarette smoke, charcoal-broiled-foods and industrial waste
by-products [1–3]. They exert a wide range of toxic eﬀects,
including carcinogenic, immunosuppressive and pro-inﬂam-
matory eﬀects. Such eﬀects have been linked to PAH-medi-
ated activation of the aryl hydrocarbon receptor (AhR), a*Corresponding author. Fax: +33 2 23 23 47 94.
E-mail address: valerie.lecureur@univ-rennes1.fr (V. Lecureur).
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doi:10.1016/j.febslet.2005.01.081ligand-activated basic–helix–loop–helix transcription factor.
Indeed, PAHs bind to cytoplasmic AhR, thereby triggering
its translocation into the nucleus, association with the AhR
nucleor translocator (ARNT) and interaction with xenobi-
otic responsive elements found in the 5 0-ﬂanking regions of
PAH-regulated genes [4]. This usually leads to enhanced
expression of these genes, which are presumed to play a ma-
jor role in deleterious eﬀects of PAHs. AhR-independent ef-
fects of PAHs have however been reported and may
contribute to their toxicity. In addition, PAHs activate mito-
gen-activated protein kinase (MAPK) signalling pathways
[5], which may be required for some of their phenotypic
activities.
Among genes regulated by PAHs, pro-inﬂammatory cyto-
kines have been identiﬁed. Indeed, increased expressions of
IL-1b, IFNc and IL-8 occurred in PAH-exposed cells, which
may contribute to the adverse inﬂammatory eﬀects due to
PAH exposure [6–8]. With respect to TNFa, another pro-
inﬂammatory cytokine, conﬂicting results have been reported
concerning its inducibility by AhR agonists. Indeed, BP treat-
ment has been shown to not aﬀect TNFa production in
mouse spleen cells [9] and cultured mouse macrophages
[10], whereas 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), a
halogenated aryl hydrocarbon known to a very potent ligand
of the AhR, has been demonstrated to enhance TNFa expres-
sion in various cell types [11,12]. The reasons for these puz-
zling results remain unknown, although they may be related
to species- or cell type-restricted regulation of TNFa.
Whether TNFa may be responsive to PAHs in human cells
is however important to precisely determine owing to the ma-
jor biological roles that plays TNFa, especially in the devel-
opment of inﬂammation, and to the fact that humans are
highly exposed to these environmental contaminants. The
present study was therefore designed to examine the eﬀects
of BP treatment on TNFa production in human macro-
phages. Such cells were chosen since (i) they constitute a ma-
jor source of TNFa [13], (ii) they are well known to be key
actors of the inﬂammatory response, (iii) they express AhR
at high levels [14] and (iv) they have already been shown to
be targeted by PAHs [15]. Our data indicate that acute BP
treatment induced TNFa secretion in primary macrophages.
This regulation was not abrogated by AhR antagonists; by
contrast, it was abolished by chemical inhibitors of extracel-
lular signal-regulated protein kinase (ERK), suggesting an
involvement of this MAPK pathway.blished by Elsevier B.V. All rights reserved.
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2.1. Chemicals and reagents
BP, lipopolysaccharide (LPS:E.coli serotype 055:B5), a-naphtoﬂav-
one and actinomycin D were provided by Sigma–Aldrich (St Louis,
MO) whereas TCDDwas from Cambridge Isotope Laboratories (Cam-
bridge, MA). The ERK inhibitors U0126 and PD98059 and the NF-jB
inhibitor Bay 11–7082 were obtained respectively from Promega (Mad-
ison, WI) and Calbiochem (La Jolla, CA). 3 0-methoxy-4 0-nitroﬂavone
(3 0M4NF) was a kind gift fromDr. T. Gasiewicz (University of Roches-
ter Medical Center, Rochester). Chemicals were commonly used as
stock solution in DMSO. Final concentration of solvent did not exceed
0.2% (v/v); control cultures received the same dose of solvent as for trea-
ted counterparts.
2.2. Isolation and culture of human macrophages
Peripheral blood mononuclear cells were obtained from blood buﬀy
coats (provided by Etablissement Franc¸ais du Sang, Rennes, France)
through Ficoll (Life Technologies, Cergy Pontoise, France) gradient
centrifugation. After a selective 2 h step of adhesion, human adherent
monocytes were cultured for 6 days in RPMI 1640 medium (Eurobio,
Les Ulis, France) supplemented with 2 mM L-glutamine, 20 IU/ml
penicillin, 20 lg/ml streptomycin and 10% decomplemented fetal bo-
vine serum (InVitrogen Corporation, NY) in the presence of 400 U/
ml human GM-CSF (sp. act. 1.2 · 108 U/mg) (Schering Plough, Lyon,
France). As previously described [15], such a protocol permits to ob-
tain pure macrophage cultures with less than 1% of contaminating
cells.Fig. 1. Induction of TNFa mRNA levels (A) and TNFa secretion (B)
in BP-treated macrophages. Primary human macrophages were either
untreated (UNT) or treated by 10 lM BP or 200 ng/ml LPS for 24 h.
(A) mRNA levels of TNFa, IL-1b, IFNc, IL-6, IL-12, CYP1A1 and b-
actin were then analysed by RT-PCR and are representative of 5
independent experiments. (B) TNFa and IL-1b secretion in culture
supernatants were quantiﬁed by ELISA. Data expressed in pg/ml are
the means ± SEM of 8 and 3 independent experiments for TNFa and
IL-1b, respectively. *, P < 0.05 when compared to untreated cells.2.3. RNA isolation and RT-PCR analysis
Total RNA was isolated from cells using the TRIzol method (Life
Technologies, Cergy Pontoise, France). Total RNA (2 lg) was reverse
transcribed using the Superscript II reverse transcriptase protocols
(Life Technologies) and equal aliquots of cDNA were subsequently
ampliﬁed by using the PCR Master mix from Promega (Madison,
WI). The gene-speciﬁc primers used were as follows: TNFa sense: 5 0-
TCAGATCATCTTCTCGAACC-30, TNFa antisense: 5 0-CAGATA-
GATGGGCTCATACC-30; IL-1b sense: 5 0-GATGGCGGCATCCA-
GCTACG-3 0, IL-1b antisense: 5 0-CTTTCAACTCGCAGGACAGG-
3 0; IL-6 sense: 3 0-ATGAACTCCTTCTCCACAAG-50, IL-6 antisense:
3 0-;GTGCCTGCAGCTTCGTCAGCA-5 0; IFN-c sense: 3 0-IFCAGG-
TCATTCAGATGTAGCG-5 0; IFN-c antisense: 3 0-GCAGGACAAC-
CAGGACTGGG-5 0; IL-12 sense: 3 0-GGGTAGCGTGCGGAGCT-
G-5 0; IL-12 antisense: 3 0-TGGATCAGAACCTAACTGC-50 and IL-
10 sense: 3 0-GAGGTCTCCAAAATCGGATCTG-5 0, IL-10 antisense:
3 0-GTTAGGGGAATCCCTCCGAG-50. The primers used for cyto-
chrome P-450 1A1 (CYP1A1) and b-actin detection were exactly those
used by van Grevenynghe et al. [16]. Analysis of b-actin mRNA levels,
not aﬀected by PAHs, was routinely performed as a control. PCR
products were resolved by electrophoresis on 1% agarose gels and
stained by ethidium bromide.
2.4. Western blot analysis
Total cellular protein extracts were obtained by incubating cells in a
lysis buﬀer containing 50 mM HEPES, 150 mM NaCl, 1 mM EGTA,
0.1% Tween 20, 10% Glycerol, 100 lM phenylmethylsulfonyl ﬂuoride
and supplemented with an EDTA-free cocktail protease inhibitor
(Roche Diagnostic, Meylan, France). Protein samples (30 lg) were
then resolved by 10% SDS–PAGE electrophoresis and electroblotted
onto nitrocellulose membranes (Bio-rad, Marne la Coquette, France).
After blocking with Tris-buﬀered saline containing 3% bovine serum
albumine and 0.1% Tween 20 for 1 h at room temperature, the mem-
branes were incubated overnight at 4 C with primary Abs directed
against phospho-ERK1/2, ERK1/2, phospho-p38 kinase and phos-
pho-c-Jun N-terminal kinase (Ozyme, St Quentin en Yvelines, France).
After incubation with appropriate horseradish peroxidase-conjugated
secondary Abs for 2 h, bands were visualized by autoradiography
using chemiluminescence.
2.5. Cytokine measurements
Levels of TNFa and IL-1b in the supernatants of macrophage cul-
tures were quantiﬁed using Duoset ELISA development system kits
obtained from R&D systems (Minneapolis, MN) whereas levels ofIFN-c and IL-12 were measured by ﬂow cytometry using the cytomet-
ric bead array kit (Becton Dickinson). Analyses were conducted
according to the manufacturers instructions.
2.6. Analysis of NF-jB DNA binding
Nuclear cell extracts (4 lg) from primary macrophages were pre-
pared using the Nuclear Extract kit and DNA binding of NF-jB
was analysed using the ELISA-based TransAMNF-jB kit according
to the manufacturers instructions (Active Motif Europe, Rixensart,
Belgium) and as previously described [17]. Brieﬂy, nuclear cell extracts
(4 lg) were incubated for 1 h in a 96-well plate to which oligonucleo-
tides containing an NF-jB consensus binding site has been immobi-
lized. After being washed, the plate was incubated for 1 h with the
rabbit anti-NF-jB p65 antibody (1:1000), which speciﬁcally detected
an epitope accessible only when NF-jB p65 is activated and bound
to its cognate oligonucleotide. The plate was then washed and incu-
bated with horseradish peroxidase-conjugated secondary antibody
(1:1000) for 1 h at room temperature. After washing, colorimetric read-
out was quantiﬁed by spectrophotometry at 450 nm. To monitor assay
speciﬁcity, wild-type and mutated consensus oligonucleotides were
used as competitors for NF-jB binding.
2.7. Statistical analysis
Data were analysed with the nonparametric Wilcoxons test or with
the Students t test. The level of signiﬁcance was P < 0.05 (\).3. Results
Primary human macrophages were exposed to 10 lM BP for
24 h; in agreement with previous data [15], such a treatment
was found to not aﬀect cell viability as demonstrated by light
microscopic examination of the cultures and measurement of
cellular exclusion of trypan blue (data not shown). We ﬁrst
analysed mRNA levels of TNFa and other inﬂammatory cyto-
kines by RT-PCR. As indicated in Fig. 1A, BP treatment en-
hanced TNFa and IL-1b mRNA amounts whereas it failed
to alter those of IFNc, IL-6 and IL-12. By contrast, mRNA
levels of all these cytokines were induced in response to a
24 h exposure to 200 ng/ml LPS, used here as a typical pro-
Fig. 2. Time-course (A) and dose-dependence (B) of TNFa expression
induction in response to BP in human macrophages. (A) Primary
human macrophages were exposed to 10 lM BP for various lengths of
time (from 0 to 24 h). Levels of TNFa and b-actin mRNAs were then
analysed by RT-PCR. (B) Macrophages were treated by various doses
of BP (from 0 to 10 lM) for 24 h. mRNAs levels of TNFa and b-actin
were then detected by RT-PCR and the results shown are represen-
tative of three independent experiments whereas TNFa secretion
analysed by ELISA represents the mean ± SEM of three independent
experiments (data expressed as % of TNFa secretion values in
untreated cells). *, P < 0.05 when compared to untreated cells.
Fig. 3. Eﬀects of TCDD on TNFa expression (A) and of the AhR antago
regulation. Primary human macrophages were untreated (UNT) or exposed
3 0M4NF or co-exposed to BP and 3 0M4NF for 12 h (B) or to 200 ng/ml LP
mRNAs levels of TNFa, IL-1b, CYP1A1 and b-actin were then detected by
experiments, whereas TNFa secretion analysed by ELISA represents the m
TNF secretion values in untreated cells). *, P < 0.05 when compared to unt
1906 V. Lecureur et al. / FEBS Letters 579 (2005) 1904–1910inﬂammatory agent. Expression of CYP1A1, a well known
PAH-regulated gene used here as a positive control of PAH
treatment, was hugely enhanced in BP-treated cells, but
remained unchanged in LPS-exposed cells (Fig. 1A). ELISA-
measurement of cytokine secretion in the supernatant of mac-
rophagic cultures further demonstrated that BP enhanced
secretion of TNFa and IL-1b release (Fig. 1B). By contrast,
BP failed to alter secretion of IFNc and IL-6 as assessed using
the cytometric bead array kit (data not shown).
Analysis of time-course of TNFa mRNA induction in BP-
treated macrophages indicated that a 4 h-exposure was suﬃ-
cient to get a maximal increase whereas longer exposure (12
to 24 h) led to a diminished up-regulation (Fig. 2A). We next
analysed the dose–response of TNFa up-regulation by BP.
As shown in Fig. 2B, the doses of 1 and 10 lM similarly in-
creased TNFa mRNA levels; they concomitantly induced
TNFa secretion. By contrast, the use of a lower BP dose
(0.1 lM) had no signiﬁcant eﬀect (Fig. 2B).
The role of AhR in TNFa up-regulation by BP was then
investigated. We ﬁrst demonstrated that TCDD, a potent
AhR ligand, increased TNFa mRNA and secretion in a sim-
ilar way than BP (Fig. 3A). It concomitantly enhanced IL-1b
and CYP1A1 mRNA expression. We secondly analysed the
eﬀects of AhR antagonists on BP-mediated TNFa regula-
tion. As shown in Fig. 3B, 3 0M4NF failed to alter TNFa
up-regulation due to BP; by contrast, it markedly decreased
IL-1b and CYP1A1 mRNA induction in BP-exposed macro-
phages. The use of a-naphtoﬂavone as AhR antagonist in-
stead of 3 0M4NF also did not aﬀect BP-mediated TNFa
up-regulation (data not shown). In the same way, 3 0M4NF
failed to counteract the inducing eﬀects of LPS towards
TNFa and IL-1b mRNA levels in macrophages; it also did
not inhibit TNFa secretion in LPS-exposed macrophagic
cells (Fig. 3C).nist 3 0M4NF on BP-mediated (B) and LPS-mediated (C) TNFa up-
to 10 lM BP or 10 nM TCDD for 24 h (A), to 10 lM BP or 1 lM
S or 1 lM 3 0M4NF or co-exposed to LPS and 3 0M4NF for 12 h (C).
RT-PCR and the results shown are representative of three independent
ean ± SEM of three independent experiments (data expressed as % of
reated cells.
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TNFa regulation were next analysed. To this aim, we studied
the putative contribution of NF-jB- and MAPK-related path-
way since (i) PAHs have been shown to activate these regula-
tory ways in the lung epithelial cell line A549 [18] and in
vascular smooth muscle cells [19] and (ii) NF-jB and MAPKs
are well known to play a major role in regulation of inﬂamma-
tory cytokines such as TNFa [20]. As shown in Fig. 4A, BP
and also TCDD failed to trigger NF-jB activation whereas,
by contrast and in agreement with previous data [21], LPS
markedly enhanced DNA binding of NF-jB by about 4.5 fold.
In addition, Bay 11–7082, known to prevent NF-jB activation
through inhibiting IkB-a phosphorylation [22], did not alter
neither TNFa mRNA levels nor TNFa secretion in BP-treated
macrophages (Fig. 4B). Bay 11–7082 was however able to de-
crease LPS-mediated induction of IL-10 mRNAs, known toFig. 4. NF-jB DNA binding activity (A) and eﬀects of Bay 11–7082
on TNFa expression in BP-treated cells (B) and on IL-10 expression in
LPS-exposed macrophages (C). (A) Primary human macrophages were
either untreated (UNT), treated by 10 lM BP, 10 nM TCDD or by
200 ng/ml LPS for 4 h. NF-jB DNA binding activity was then
analysed as described in Materials and Methods. Wild-type (WT) or
mutated (MUT) consensus oligonucleotides for NF-jB binding were
used as competitors of nuclear extracts prepared from untreated cells
to verify the speciﬁcity of the assay. Values, expressed as optical
density (OD) units, are the mean ± SEM of three independent
experiments. *, P < 0.05 comparatively to untreated cells. (B) Primary
macrophages were either untreated (UNT) or treated by 10 lM BP or
10 lM Bay 11–7082 or co-exposed to BP and Bay 11–7082 for 12 h.
mRNAs levels of TNFa and b-actin were then detected by RT-PCR
and the results shown are representative of three independent
experiments whereas TNFa secretion analysed by ELISA represents
the mean ± SEM of at least three independent experiments (data
expressed as % of TNFa secretion values in untreated cells). *, P < 0.05
comparatively to untreated cells. (C) Primary macrophages were either
untreated (UNT) or treated by 200 ng/ml LPS or 10 lM Bay 11–7082
or co-exposed to LPS and Bay 11–7082 for 12 h. mRNAs levels of IL-
10 and b-actin were then detected by RT-PCR and the results shown
are representative of three independent experiments.depend on NF-jB activation [23] (Fig. 4C), thus demonstrat-
ing that this NF-jB inhibitor was fully active in our hands.
With respect to MAPKs, BP was found to activate ERK1/2
pathway in human macrophages since it enhanced ERK1/2
phosphorylation as demonstrated by western blotting, espe-
cially after a 4 h-exposure (Fig. 5A). It did not however modify
levels of phospho-c-Jun N-terminal kinase and only slightly in-
creased levels of phospho-p38 kinase after a 24 h exposure,
indicating that BP treatment did not aﬀect in a major way both
p38 kinase and c-JUN N-terminal kinase pathways. Macro-
phages exposed to LPS for 30 min, used here as positive con-
trols, displayed a marked activation of ERK, p38 and c-JUN
N-terminal kinases (Fig. 5A). To further determine the role
of ERK1/2 phosphorylation in BP-mediated TNFa up-regula-
tion, we investigated the eﬀects of two diﬀerent inhibitors of
ERK activation, U0126 and PD98056, which act through
inhibiting MAPK kinases mitogen-activated protein/ERK1/2
kinases. These inhibitors were found to counteract ERK1/2
phosphorylation in BP-treated macrophages (data not shown).
They suppressed up-regulation of TNFa secretion occurring in
response to BP and TCDD (Fig. 5B); they concomitantly abol-
ished up-regulation of TNFa mRNA due to BP-treatment
(Fig. 5C). LPS-induced TNFa secretion was also decreased
by U0126 (data not shown). By contrast, ERK inhibitors failed
to alter CYP1A1 mRNA induction in BP-exposed macro-
phages (Fig. 5C); exposure to U0126 alone even induced
CYP1A1 expression, which most likely reﬂects its ability to
activate AhR [24].4. Discussion
PAHs have been previously shown to regulate expression of
several cytokines, especially pro-inﬂammatory cytokines such
as IL-1, IFNc and IL-8 [6–8]. The data reported in the present
study demonstrated that TNFa, well known to play a major
role in inﬂammatory processes, is also a target for PAHs in hu-
man macrophages. Indeed, acute treatment by BP, used here
as a referent PAH, was found to induce both TNFa mRNA
levels and TNFa secretion in primary human macrophages.
By contrast, BP has been reported to not induce TNFa secre-
tion in murine macrophagic RAW 264.7 cells [10]; in addition,
intratracheal instillation of BP to rats suppressed TNFa re-
lease in LPS-activated alveolar macrophages [25]. The reasons
for these controversial results with respect to TNFa regulation
in response to PAHs remain to be determined. They may be
linked to species- or cell type-restricted regulation. A diﬀerent
response according to the length of exposure may also account
for these discrepancies; indeed, sub-acute and chronic expo-
sure of monocytic cells to PAHs has been shown to markedly
alter their functionality [16], including their response to LPS
and the secretion of cytokines. By contrast, human macro-
phages acutely treated by BP are viable and they remain able
to produce cytokines as demonstrated by the up-regulation
of IL-1b and TNFa secretion.
Besides BP, TCDD, a very potent AhR ligand, was also
found to trigger TNFa secretion in primary macrophages, sug-
gesting an implication of AhR. Surprisingly, AhR antagonists
such as 3 0M4NF and a-naphtoﬂavone failed to inhibit BP-
mediated TNFa up-regulation in human macrophages; these
compounds however strongly decreased BP-related induction
Fig. 5. ERK activation in BP-treated macrophages (A) and eﬀects of chemical ERK-inhibitors on TNFa secretion (B) and on TNFa mRNA levels
(C) in BP-treated macrophages. (A) Primary macrophages were either untreated (UNT), exposed to 10 lM BP for 0.5, 4, 8 or 24 h or treated by
200 ng/ml LPS for 30 min. Phospho-ERK1/2, ERK 1/2, phospho-p38 kinase and phospho-JNK levels were then determined by western blotting as
described in Materials and Methods. Data shown are representative of three independent experiments. (B) Primary human macrophages were either
untreated (UNT) or treated by 10 lMBP, 10 nM TCDD, 5 lMU0126 or 25 lM PD98059 or co-treated by BP and U0126, BP and PD98059, TCDD
and U0126 or TCDD and PD98059 for 6 h. TNFa secretion was then analysed by ELISA and represents the mean ± SEM of three independent
experiments (data expressed as % of TNFa secretion values in untreated cells not exposed to ERK inhibitors). *, P < 0.05 when compared to control
cells not exposed to ERK inhibitors. (C) Primary human macrophages were either untreated (UNT) or treated by 10 lM BP, 5 lMU0126 or 25 lM
PD98059 or co-treated by BP and U0126 or by BP and PD98059. mRNAs levels of TNFa, CYP1A1 and b-actin were then detected by RT-PCR and
the results shown are representative of three independent experiments.
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indicating they were fully active in our hands. In addition,
the MEK inhibitor U0126 did not induce TNFa expression
in macrophages although it has been reported to be a potent
activator of AhR and consequently enhanced CYP1A1 mRNA
levels [24]. Taken together, these data may indicate that TNFa
is not regulated through typical activation of AhR in BP-ex-
posed macrophages. The fact that AhR-related xenobiotic
responsive elements have not been found in the 5 0-ﬂanking re-
gion of the human TNFa gene [26] fully supports this hypoth-
esis. Interestingly, PAHs and TCDD have already been
reported to exert AhR-independent eﬀects such as suppression
of the cell cycle point MAD2 [27], induction of apoptosis in
hematopoietic cell lines and activation of some MAPK [28].
Prostaglandin endoperoxyde H synthase-2 induction by dioxin
has also been suggested to be not mediated by the classical
AhR way in rat hepatocytes [29]. Whether these AhR-unre-
lated signalling pathways share common regulatory mecha-
nisms remains to be determined. In this context, it may be
interesting to consider the role of calcium. Indeed, this second
messenger, which participates to regulation of many cellular
functions, including TNFa secretion in human macrophages
[30], has been shown to be a target for both PAHs and TCDD
[31].
Induction of TNFa expression in BP-treated macrophages
probably requires active transcription since it was fully inhib-
ited by the transcription inhibitor actinomycin D (data not
shown). By contrast, it is unlikely to involve activation of
NF-jB. Indeed, BP and also TCDD failed to induce DNAbinding activity in primary macrophages and the NF-jB inhib-
itor Bay 11–7082 did not abolish TNFa up-regulation in
BP-treated macrophages. NF-jB activity has been however
demonstrated to be induced in BP-exposed vascular smooth
muscle cells and to be implicated in the PAH-related regula-
tion of cyclooxygenase-2 [19]. It has also been shown to play
a major role in TNFa regulation in LPS-exposed macrophages
[21] although an NFjB-independent increase of TNFa pro-
duction in macrophages has also been reported after a treat-
ment by dithiocarbamate [32] or PMA [33].
Between MAPKs, only ERK appears to likely contribute in
a major way to BP-related regulation of TNFa in human mac-
rophages. Indeed, this MAPK, previously known to be in-
volved in LPS-regulation of TNFa [34], was found to be
markedly activated by BP, unlike p38 kinase and c-JUN N-ter-
minal kinase; this ERK activation, like TNFa mRNA up-reg-
ulation, was rather an early event in BP-exposed cells since it
occurred for a 4 h BP-treatment and its inhibition using the
MEK inhibitors U0126 and PD98056 led to a suppression of
TNFa induction occurring in BP- or TCDD-treated macro-
phages. A similar activation of ERK in response to BP was de-
scribed in human lung carcinoma cells independently of AhR
[28] and has been shown to be implicated in up-regulation of
NAD(P)H quinone reductase activity in HT29 colon adenoma
carcinoma cells [5]. Moreover, ERK is thought to be needed
for TCDD-stimulated IL-1b expression in human keratino-
cytes [35]; it also functions synergistically with AhR to
suppress peroxisome proliferator-activated receptor-c1 expres-
sion [36]. Taken together, these data suggest that ERK
V. Lecureur et al. / FEBS Letters 579 (2005) 1904–1910 1909activation may play a crucial role for some phenotypic eﬀects
of AhR agonists.
The exact consequences of TNFa up-regulation in response
to PAHs in term of general toxicity of these chemicals remain
to be determined, especially after in vivo exposure. Owing to
the major role play by macrophages and TNFa in inﬂamma-
tion processes, it is however tempting to speculate that PAH-
mediated TNFa secretion may contribute in a major way to
pro-inﬂammatory eﬀects of these environmental contaminants.
In addition, it is noteworthy that BP was active on TNFa reg-
ulation when used at 1 lM (250 ng/g), a relatively low concen-
tration close to those found in some foods (up to 50 ng/g) [37],
in tobacco smoke (20–40 ng/cigarette) [38] or in contamined
soil, suggesting that humans may be exposed to PAH concen-
trations putatively triggering TNFa release. Moreover, TNFa
induction occurred for a relative short time-treatment to BP
(4 h), indicating that acute and transient exposure to PAHs
is suﬃcient to enhance TNFa secretion. Interestingly, the
macrophages used in the present study, derived from GM-
CSF-treated monocytes, are thought to mimic alveolar macro-
phages [39], which likely represent a choice target for PAHs
owing to the importance of air contamination for human. It
should however be kept in mind that BP-exposure of macro-
phages did not lead to a general pro-inﬂammatory eﬀect simi-
lar to that triggered by LPS. Indeed, some major LPS-induced
cytokines such as IL-6, IL-12 and IFNc were not aﬀected by
BP in human macrophages. In addition, as already discussed
above, BP failed to activate transduction pathways such as
NF-jB, p38 and c-JUN N-terminal kinases which constitute
major molecular targets for LPS [40,41] thus highlighting
marked diﬀerence between macrophagic responses to PAHs
and LPS. Some similarities however exist, especially owing to
the role of ERK and the lack of involvement of AhR. Indeed,
both BP- and LPS-mediated inductions of TNFa were de-
creased by the ERK inhibitor U0126, whereas they were not
altered by the AhR antagonist 3 0M4NF.
In summary, our data indicate that acute treatment by the
environmental contaminant BP induces TNF secretion in hu-
man macrophages in an ERK-dependent manner. Such a reg-
ulation may likely contribute to the toxicity of PAHs,
especially to their pro-inﬂammatory eﬀects.
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